🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › South Carolina › Charleston

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Charleston, SC keessatti

Qorannoo 6 Kansaar Onnee Triple-Negative f Charleston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Namoota walitti qabaa jiraSadarkaa 3
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs)

Namoota walitti qabaa jiraSadarkaa 2
  • Medical University of South Carolina Hollings Cancer Center,, Charleston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT07743190

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Normunity Investigational Site, Charleston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07182149

NeoCARD: Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer Patients

Namoota walitti qabaa jiraSadarkaa 2
  • Medical University of South Carolina, Charleston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT06845319

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Namoota walitti qabaa jiraSadarkaa 2
  • Medical University of South Carolina, Charleston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT04468061

Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti

Qorannoo biroo Charleston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.